google-site-verification: googlef34d17771a9ef049.html Blog | cba-consulting
  • LinkedIn Social Icon

© 2017 by Cambridge Biostrategy Associates LLC. Proudly created with Wix.com

Please reload

Follow Us

September 19, 2017

In my previous blog post, I suggested that the market size for gene-modified T-cell therapies would be roughly $9 Bn in 10 years, with a range of around $5 - $20 Bn. In this post I will provide some structure for this wide range by breaking out five key factors that wi...

September 5, 2017

In the NY Times article, “Take the Generic, Patients Are Told. Until They Are Not.”, Pharmacy Benefit Managers (PBMs) were called out for pushing branded products over generics to patients.

PBMs are primarily responsible for developing and maintaining the formulary, con...

Please reload

  • LinkedIn Social Icon
Please reload

Recent Posts
Search By Tags
Featured Posts

Artificial intelligence in pharma, health care is at the crossroads of hype and reality

December 7, 2018

1/6
Please reload

Archive
Please reload